Kupando GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors (NCT07600476) | Kupando GmbH | 2026-07-03 |
Track Kupando GmbH automatically
Every clearance here is in the API, with alerts when new ones post.